Patents by Inventor Matthieu Pichaud

Matthieu Pichaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOUNDS FOR CANCER THERAPY
    Publication number: 20230201322
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of sequences described in the specification.
    Type: Application
    Filed: August 30, 2022
    Publication date: June 29, 2023
    Inventors: Laurent CHENE, Alban MATHIEU, Matthieu PICHAUD, Francesco STROZZI
  • Immunogenic compounds for cancer therapy
    Patent number: 11478538
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of peptides having amino acid similarity with IL13RA2, the said antigenic peptide being selected in the group consisting of sequences described in the specification.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: October 25, 2022
    Assignee: ENTEROME S.A.
    Inventors: Laurent Chene, Alban Mathieu, Matthieu Pichaud
  • Immunogenic compounds for cancer therapy
    Patent number: 11478537
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of sequences described in the specification.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: October 25, 2022
    Assignee: ENTEROME S.A.
    Inventors: Laurent Chene, Alban Mathieu, Matthieu Pichaud, Francesco Strozzi
  • Gene signatures of inflammatory disorders that relate to the liver
    Patent number: 10626471
    Abstract: This invention is related to the area of characterization of inflammation in relation with the gut microbiota, in metabolic and autoimmune disorders. In particular, it relates to the identification of gene signatures which can be used as a marker predictive of inflammation associated diseases, such as liver-related metabolic disorders, in particular to the evolution of benign steatosis towards its most severe forms (steatohepatitis and cirrhosis) or autoimmune disorders, in particular inflammatory bowel diseases (Crohn's and Ulcerative Colitis). These gene signatures can therefore be used as a means of diagnosis, prognosis, stratification for drug studies, for monitoring patient and for assigning an appropriate treatment.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: April 21, 2020
    Assignees: ENTEROME, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
    Inventors: Matthieu Pichaud, Pierre Rimbaud, Stanislav Ehrlich
  • Immunogenic Compounds For Cancer Therapy
    Publication number: 20200113983
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of sequences described in the specification.
    Type: Application
    Filed: October 9, 2017
    Publication date: April 16, 2020
    Inventors: Laurent CHENE, Alban MATHIEU, Matthieu PICHAUD, Francesco STROZZI
  • Immunogenic Compounds For Cancer Therapy
    Publication number: 20190388532
    Abstract: The invention relates to an immunogenic compound comprising an antigenic peptide having amino acid similarity with a tumor antigen, which antigenic peptide is selected in the group consisting of peptides having amino acid similarity with IL13RA2, the said antigenic peptide being selected in the group consisting of sequences described in the specification.
    Type: Application
    Filed: October 9, 2017
    Publication date: December 26, 2019
    Inventors: Laurent CHENE, Alban MATHIEU, Matthieu PICHAUD
  • GENE SIGNATURES OF INFLAMMATORY DISORDERS THAT RELATE TO THE LIVER
    Publication number: 20180251819
    Abstract: This invention is related to the area of characterization of inflammation in relation with the gut microbiota, in metabolic and autoimmune disorders. In particular, it relates to the identification of gene signatures which can be used as a marker predictive of inflammation associated diseases, such as liver-related metabolic disorders, in particular to the evolution of benign steatosis towards its most severe forms (steatohepatitis and cirrhosis) or autoimmune disorders, in particular inflammatory bowel diseases (Crohn's and Ulcerative Colitis). These gene signatures can therefore be used as a means of diagnosis, prognosis, stratification for drug studies, for monitoring patient and for assigning an appropriate treatment.
    Type: Application
    Filed: May 7, 2018
    Publication date: September 6, 2018
    Inventors: Matthieu PICHAUD, Pierre RIMBAUD, Stanislav EHRLICH
  • Gene signatures of inflammatory disorders that relate to the liver
    Patent number: 10036074
    Abstract: This invention is related to the area of characterization of inflammation in relation with the gut microbiota, in metabolic and autoimmune disorders. In particular, it relates to the identification of gene signatures which can be used as a marker predictive of inflammation associated diseases, such as liver-related metabolic disorders, in particular to the evolution of benign steatosis towards its most severe forms (steatohepatitis and cirrhosis) or autoimmune disorders, in particular inflammatory bowel diseases (Crohn's and Ulcerative Colitis). These gene signatures can therefore be used as a means of diagnosis, prognosis, stratification for drug studies, for monitoring patient and for assigning an appropriate treatment.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: July 31, 2018
    Assignees: INSTITUT PASTEUR, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Matthieu Pichaud, Pierre Rimbaud, Stanislav Ehrlich
  • GENE SIGNATURES OF INFLAMMATORY DISORDERS THAT RELATE TO THE LIVER
    Publication number: 20160068890
    Abstract: This invention is related to the area of characterization of inflammation in relation with the gut microbiota, in metabolic and autoimmune disorders. In particular, it relates to the identification of gene signatures which can be used as a marker predictive of inflammation associated diseases, such as liver-related metabolic disorders, in particular to the evolution of benign steatosis towards its most severe forms (steatohepatitis and cirrhosis) or autoimmune disorders, in particular inflammatory bowel diseases (Crohn's and Ulcerative Colitis). These gene signatures can therefore be used as a means of diagnosis, prognosis, stratification for drug studies, for monitoring patient and for assigning an appropriate treatment.
    Type: Application
    Filed: October 17, 2013
    Publication date: March 10, 2016
    Inventors: Matthieu Pichaud, Pierre Rimbaud, Stanislav Ehrlich